Kiromic BioPharma, Inc. Securities Litigation
Checked October 14, 2026 against the official notice · Edited by Ferhat Abdullahoglu
Individuals who purchased or acquired Kiromic BioPharma, Inc. common stock during specific periods may be eligible for a payment from a $1,225,000 settlement fund. The amount each claimant receives will depend on the number of valid claims submitted and will be reduced by attorneys' fees and expenses.
Who qualifies
- From June 25, 2021.
- Anywhere in the United States.
- Products: Kiromic common stock.
“You may have purchased or acquired (a) Kiromic common stock pursuant and/or traceable to the Offering Documents (defined in the Settlement) and/or (b) Kiromic common stock between June 25, 2021 and February 2, 2022, both dates inclusive and subject to 15 U.S.C.”From the court-approved notice
What you can get
These are the amounts the settlement publishes. Shares of a fund depend on how many people file: what pro rata means.
How to file
- 1. Check that the class description above fits you.
- 2. File on the official claim form by December 14, 2026. It usually takes a few minutes.
Key dates
When settlements pay, and what can delay it.
Is this settlement legit?
Yes. It's a court-approved class action settlement in the U.S. District Court for the Southern District of New York (case 1:22-cv-06690 (JHR)), run by Strategic Claims Services. The official site is strategicclaims.net. You never pay to file a claim. How to check a settlement notice.
Related settlements
ClaimWell summarizes the official notice so it's easier to read. It isn't legal advice; the official settlement site is the authority on who qualifies and what each claim pays.